Cannabis Research
Cannabis and CBD Relief for IBD: What Patients Are Saying

Inflammatory bowel disease (IBD) is a complex, chronic condition that affects millions worldwide, often forcing patients to live with debilitating symptoms and few long-term solutions. As science continues to explore both conventional and alternative therapies, new research is shining a spotlight on cannabis and cannabidiol (CBD) oil as potential tools for symptom relief. A recent study1 published in Academia Medicine offers compelling insights into how patients perceive and use plant-based therapies to manage IBD.
Understanding Inflammatory Bowel Disease (IBD)
IBD is an umbrella term used to describe disorders that involve chronic inflammation of the digestive tract, including Crohn’s disease and ulcerative colitis. These conditions can cause painful symptoms, including:
- Abdominal cramping
- Diarrhea or constipation
- Fatigue
- Weight loss
- Rectal bleeding
- Nausea and vomiting
While the exact cause of IBD is still not fully understood, it is believed to result from an abnormal immune response that attacks the gastrointestinal tract. Treatment typically involves medications such as corticosteroids, immunosuppressants, or biologics, and in severe cases, surgery. However, many patients seek complementary therapies to help ease the daily burden of symptoms, and increasingly, cannabis is entering that conversation.
What The Study Reveals
A team of researchers conducted a 37-question survey among 139 individuals (93 with IBD and 33 without) to explore how cannabis and CBD oil are being used, and what outcomes users are experiencing.
Key Findings:
- Cannabis use was more common among IBD patients than in those without the condition (53.8% vs. 45.5%).
- A striking 86.8% of IBD patients supported medical cannabis use, compared to 84.9% of non-IBD participants.
- 63.2% of IBD patients believed cannabis had a somewhat to extremely beneficial effect on their symptoms.
- Similarly, 56.6% reported benefit from CBD oil, even in the absence of THC (the psychoactive compound in cannabis).
- Traditional medications like corticosteroids and biologics were still viewed as helpful, but cannabis was seen as a valuable complementary therapy.
While the study emphasized self-reported data, it nonetheless paints a clear picture: many people living with IBD are not only using cannabis and CBD oil but are also experiencing real relief from them.
| Symptom | Reported Relief (Cannabis) | Reported Relief (CBD Oil) |
|---|---|---|
| Abdominal Pain | High | Moderate |
| Nausea/Vomiting | High | Moderate |
| Anxiety/Depression | Moderate | Moderate |
| Fatigue | Low | Low |
How Does Cannabis Help With IBD Symptoms?
Patients in the study reported significant relief from a wide range of symptoms, including abdominal pain, general pain, stress, anxiety, depression, as well as nausea and vomiting.
Interestingly, patients with Crohn’s disease appeared to benefit more than those with ulcerative colitis in certain symptom categories. This difference could be due to the way each disease affects the gastrointestinal tract, or how individual symptom profiles respond to cannabinoids.
Cannabinoids interact with the endocannabinoid system, which plays a role in regulating inflammation, gastrointestinal function, immune response, and pain perception. THC and CBD are both known to have anti-inflammatory and analgesic properties, which may help explain their impact on IBD symptoms.
Cannabis and CBD for Opioid Reduction and Symptom Remission in IBD
One of the more encouraging findings from the study was that 19.4% of IBD patients reported reduced opioid use after starting cannabis or CBD oil. Given the well-documented risks associated with long-term opioid use, this suggests that cannabis could play a role in harm reduction strategies for managing chronic pain in IBD.
Even more notably, 14.5% of patients reported that cannabis or CBD oil led to remission of their IBD symptoms, highlighting the potential of cannabis-based therapies to do more than just relieve surface-level symptoms.
A Shift in Patient Perspectives
The overwhelming support for cannabis and CBD oil among both IBD and non-IBD participants reflects a broader cultural shift toward plant-based and holistic approaches to health. While traditional treatments remain essential, especially in controlling disease progression and preventing complications, many patients are looking for adjunct options that give them more control over their day-to-day well-being.
This study reinforces the importance of patient voices in shaping research and policy, especially when it comes to chronic conditions that significantly impact quality of life. For those living with IBD, feeling heard and having more choices in treatment can be just as valuable as the therapies themselves.
The Future of Cannabis in IBD Treatment
Living with inflammatory bowel disease often means navigating a lifetime of unpredictable symptoms, exhausting treatment cycles, and emotional strain. For many, cannabis and CBD oil offer more than a momentary escape; they represent a potential path to relief and restored quality of life.
The recent study from Academia Medicine adds valuable evidence to the conversation, highlighting not only the growing use of cannabis among IBD patients but also evidence that plant-based therapies are helping patients. While more research is needed, the message from patients is loud and clear: cannabis is helping and it’s time the medical community took note.
Studies Referenced:
1. Lala, A., Rodriguez-Palacios, A., Cominelli, F., & Raffner Basson, A. (2025). Inflammatory bowel disease patients believe cannabis and cannabidiol oil relieve symptoms. Academia Medicine, 2(2). https://doi.org/10.20935/AcadMed7773












